Effect of recombinant human erythropoietin on the expression of NF-κB in rats with traumatic brain injury

Zhongguo Bian,Zhiyuan Qian,Hechun Shen,Wei Qian,Qingyong Li

DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2014.16.017

2014-01-01

Abstract:ObjectiveTo observe the effect of recombinant human erythropoietin (rhEPO) on the expression of the NF-κB activity and expression of NF-κB mRNA change after traumatic brain injury (TBI) in rats.MethodsRat TBI model was established by improved Feeney method. 84 male rats were randomly divided into TBI group (n=42) and TBI-rhEPO group (n=42). The neurological severity score (NSS) was performed following TBI. The pathological change was observed through HE staining, and the activity of NF-κB and TNF-α was judged by immunohistochemistry staining. The mRNA level of NF-κB was detected by RT-PCR.Results NSS of TBI-rhEPO group was significantly lower than the TBI group from 12 h to 7 d post injury (P<0.05), the rest had no significant difference (P>0.05). Expression of NF-κB mRNA and proteins around the lesions after traumatic brain injury was decreased obviously in TBI-rhEPO group (P<0.05).Conclusion Application of rhEPO in early traumatic brain injury maybe through down-regulating the TNF-α and NF-κB expression and inhibiting NF-κB activity to reduce inflammatory reaction and plays a role in protecting the secondary brain injury.